BioInnovation Institute launches Venture Lab program with intake of innovative early-stage companies

First cohort of companies comprise seven start-up initiatives developing pioneering science for a range of therapeutic, health tech and bioindustrial applications

COPENHAGEN, DenmarkSept. 14, 2021 /PRNewswire/ — BioInnovation Institute (BII), an international commercial foundation with a non-profit objective incubating and accelerating world-class life science research, today announces the first cohort of participants in the Venture Lab acceleration program for early-stage companies. Comprising a pan-European spread of start-up initiatives and university research projects, the seven ventures are developing revolutionary science across BII’s three sector specialised areas – therapeutics, bioindustrials and health tech.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH